Sharon mates phd
Webb2 apr. 2024 · Sharon Mates, PhD Intra-Cellular Therapies recently announced the expansion of its central nervous system (CNS) pipeline with ITI-1284 ODT-SL, with plans … Webb18 nov. 2024 · Mates received her BS from the Ohio State University and her PhD from the University of Washington, and completed her postdoctoral fellowships at The …
Sharon mates phd
Did you know?
WebbSharon Mates, Intra-Cellular Therapies Inc: Profile and Biography - Bloomberg Markets Bloomberg Connecting decision makers to a dynamic network of information, people … Webb316 ABSTRACTS same population to test its efficacy in not just Pacific tolerance test (OGTT), hyperinsulinemic-euglycemic clamp, Islanders, but all youth
Webb31 jan. 2024 · “Sharon was an outstanding Principal Investigator for the two projects below. She met or exceeded all expectations with scope, … WebbLumateperone (ITI 007) in the Treatment of Bipolar Depression: Results from a Randomized Clinical Trial Ian D’Souza, PhD1, Suresh Durgam, MD1, Andrew Satlin, MD1, …
Webbsharon mates phd option exercises and stock outstanding equity awards -1 outstanding equity awards 2024 grants of planbased a summary compensation equity awards ... WebbDr. Mates received her B.S. from the Ohio State University and her Ph.D. from the University of Washington, and completed her postdoctoral fellowships at The Massachusetts …
Webb16 maj 2024 · Sharon Mates, PhD, Co- Founder, Chairman, and Chief Executive Officer, of Intra-Cellular Therapies, is the recipient of the ISCDD 2024 Leadership Award. Rho has announced that Laura Helms Reece, DrPH and co-CEO of the company, was named a CEO of the Year by the Triangle Business Journal.
Webb9 mars 2024 · Sharon Mates owns over 62,335 units of Intra-Cellular Therapies Inc stock worth over $63,410,335 and over the last 9 years he sold ITCI stock worth over … csorwe fanartWebb14 okt. 1996 · NORTH AMERICAN VACCINE GROUP B STREP VACCINE IN PHASE II trial sponsored by the National Institute of Allergy & Infectious Diseases, North American … ealing broadway to chiswick parkWebbBoard of Directors Sharon Mates, PhD, Chairman, Founder, President & Chief Executive Officer, Intra-Cellular Therapies Christopher Alafi, PhD, General Partner, Alafi Capital Richard Lerner, MD, Institute Professor & Former … cso safe and soundWebbCo-Founder and Director, Royalty Pharma; Founder and CEO, Syntax LLC, Locus Analytics; Managing Member, Scientia Ventures. csos and body camerasWebb20 dec. 2024 · “Caplyta is the only medication approved by the FDA to treat depressive disorders associated with bipolar I or bipolar II as both monotherapy and adjunctive … csor workoutWebb1 feb. 2024 · ; Sharon Mates, PhD 1 ; Andrew Satlin, MD 1 ; and Robert Davis, PhD 1 1 Intra-Cellular Therapies Inc., New York, NY ABSTRACT:Background: Lumateperone is afirst-in … csos and hoaWebb23 dec. 2024 · Intra-Cellular Therapies announced early Monday morning lumateperone (CAPLYTA) had received approval from the FDA and the company expects the treatment … cso safety course